2,4-Diaryl-5,6-dihydro-1,10-phenanthroline and 2,4-diaryl-5,6-dihydrothieno[2,3-h] quinoline derivatives for topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study
- Bioorg Chem. 2012 Feb;40(1):67-78. doi: 10.1016/j.bioorg.2011.09.001.
- 1. College of Pharmacy, Yeungnam University, Kyongsan 712-749, Republic of Korea.
- 2. College of Pharmacy, Division of Life & Pharmaceutical Sciences, Ewha Womans University, Seoul 120-750, Republic of Korea.
- 3. College of Pharmacy, Cha University, Pochon 487-010, Republic of Korea.
- 4. College of Pharmacy, Chonnam National University, Kwangju 500-757, Republic of Korea.
- 5. College of Pharmacy, Division of Life & Pharmaceutical Sciences, Ewha Womans University, Seoul 120-750, Republic of Korea. Electronic address: [email protected].
- 6. College of Pharmacy, Yeungnam University, Kyongsan 712-749, Republic of Korea. Electronic address: [email protected].
Designed and synthesized thirty-two 2,4-diaryl-5,6-dihydro-1,10-phenanthroline and 2,4-diaryl-5,6-dihydrothieno[2,3-h] quinoline derivatives as rigid analogs of 2,4,6-trisubstituted pyridines were evaluated for Topoisomerase I and II inhibitory activities as well as cytotoxicities against several human Cancer cell lines. Structure-activity relationship study showed that [2,2';6',2"]-terpyridine skeleton is important for the cytotoxicity against several human Cancer cell lines.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Drug IntermediateResearch Areas: Others